Come up with a name for your new list and we'll add to it:
Juventas Therapeutics raised a round of funding on , . Investors include
The Global Cardiovascular Innovation Center.
Juventas Therapeutics, formerly AcelleRx Therapeutics, Juventas Therapeutics is a privately held, clinical stage biotechnology company focused on developing non-viral gene therapies to treat advanced …